Huwel Lifesciences

About Huwel Lifesciences

Huwel makes molecular diagnostics that historically sat behind a hard cost ceiling — TB confirmation, HPV screening, infectious disease panels — accessible and affordable for state procurement programmes. Their approach combines indigenous reagent development, locally-manufactured instruments and an obsessive focus on per-test economics, so screening programmes can be designed around what the public system can actually pay for. The portfolio of products is squarely aimed at India's biggest public-health priorities — TB elimination, cervical cancer screening and outbreak preparedness.